National Prevalence of Extended-Spectrum Beta-lactamase Producing Enterobacteriaceae (ESBL) in the Ambulatory and Acute Care Settings in the United States in 2015

  • Hoffman-Roberts H
  • Luepke K
  • Tabak Y
  • et al.
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Methods. Susceptibility data from non-duplicate organisms including E. coli, K. pneumoniae, and P. mirabilis were collected from 346 hospitals. ESBL was identified per NHSN definitions. Organisms were classified into ambulatory, admission, and hospital-onset (HO) periods based on collection time. All data were consolidated into CMS National Hospital Data Provider IDs. The raking method was applied per CMS national hospital distribution by location, teaching status, urban/rural status, and bed size to project the national prevalence estimates.

Cite

CITATION STYLE

APA

Hoffman-Roberts, H., Luepke, K., Tabak, Y. P., Mohr, J., Johannes, R. S., & Gupta, V. (2016). National Prevalence of Extended-Spectrum Beta-lactamase Producing Enterobacteriaceae (ESBL) in the Ambulatory and Acute Care Settings in the United States in 2015. Open Forum Infectious Diseases, 3(suppl_1). https://doi.org/10.1093/ofid/ofw172.233

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free